Evaluation of Cyclin-Dependent Kinase Inhibitor 2A and Hepatocyte Nuclear Factor-1A Gene Polymorphisms in Coronary Artery Diseases
Last updated: 01 Jan 2025
10.21608/zumj.2022.161460.2636
Coronary artery diseases, Cyclin-Dependent Kinase Inhibitor 2A, Hepatocyte Nuclear Factor-1A
Magdy
ibrahimm
medical biochemistry, faculty of medicine, Zagazig university, Egypt
magdymohammed1233@gmail.com
zagazig
abdelsalam
sherif
cardiology department, faculty of medicine, Zagazig university, Egypt
abusherif60@gmail.com
zagazig
dina
mohamed
salah
medical biochemistry, faculty of medicine,zagazig university, Egypt
denad9baa@gmail.com
zagazig
walaa
samy
medical biochemistry, faculty of medicine, Zagazig university, Egypt
dr.lolosamy_2010@yahoo.com
zagazig
30
3
46681
2024-05-01
2022-09-09
2024-05-01
859
868
1110-1431
2357-0717
https://zumj.journals.ekb.eg/article_260159.html
https://zumj.journals.ekb.eg/service?article_code=260159
28
Original Article
273
Journal
Zagazig University Medical Journal
https://zumj.journals.ekb.eg/
Evaluation of Cyclin-Dependent Kinase Inhibitor 2A and Hepatocyte Nuclear Factor-1A Gene Polymorphisms in Coronary Artery Diseases
Details
Type
Article
Created At
30 Dec 2024